Recently, SkyWalker™ Orthopedic Surgical Robot (hereinafter referred to as SkyWalker™) developed by MicroPort NaviBot (Suzhou) Co., Ltd., a subsidiary of Shanghai MicroPort MedBot (Group) Co., Ltd., has received multiple orders in Europe, North America, South America, Oceania, and other regions. It has also won bids in several Chinese hospitals, with the cumulative delivery of orders exceeding 20 units. The sales of SkyWalker™ robot have achieved both domestic and international success, making it the first and only Chinese-developed orthopedic surgical robot to achieve global certification and sales. This milestone signifies the acceleration of MicroPort^® MedBot^®  global strategy and sets a new benchmark for the globalization of the domestic surgical robot industry.

01

Global Expansion and Marketing in Europe and America

Originating from China, the Birthplace of Robotic Surgery Technology

As the first Chinese-developed surgical robot to obtain market certifications in multiple continents, SkyWalker™ has made commercial breakthroughs in countries known for manufacturing high-end medical equipment, such as the United States and Germany. It has successfully completed nearly a hundred cases of robot-assisted surgeries overseas, including consecutive surgeries.

This means that while imaging technology and surgical robot technology in the field of orthopedics originated in Europe and America, SkyWalker™, with independent intellectual property rights, has achieved market sales in countries like the United States and Europe, leading to a "reverse import" of high-end medical equipment from China to developed countries, showcasing the profound impact of the internationalization of the Chinese-developed surgical robot industry. SkyWalker™ has gained unanimous recognition from top hospitals and patients in Europe and America, gaining reputation both domestically and internationally, thanks to its brand influence and remarkable product performance.

SkyWalker™ excels in precise bone cutting, fast intraoperative registration, and smooth surgical flow. The innovative multi-purpose bone cutting plate not only facilitates more efficient bone cutting but also aligns with the surgeons' operating habits, reducing the learning curve and enhancing system usability. Recently, renowned journal "International Orthopaedics," hosted by the International Society of Orthopaedics, published a large-scale clinical comparative study of SkyWalker™ and top international robotic products, along with relevant clinical data, confirming these points. The study shows that SkyWalker™ achieves comparable clinical outcomes to top international orthopedic surgical robots in terms of accuracy of lower limb alignment, surgical time, blood loss, as well as clinical functional evaluations of the knee joint at 6 months and 1 year post-operation. This indicates that robot-assisted total knee arthroplasty (TKA) with SkyWalker™ is at an internationally leading level in terms of surgical accuracy and clinical efficacy.

 In June of this year, four orthopedic experts from Poland visited Shanghai Ninth People's Hospital to observe and learn from Director Li Huiwu's use of SkyWalker™ robot to assist in performing two total knee arthroplasty surgeries. The surgical robot's intraoperative assistance capabilities, intelligent navigation capabilities, and precision and efficiency in surgery received high praise from the visiting Polish doctors.

02

Domestic Innovation, Versatile Applications

Demonstrating Increased Clinical Value and Cost-effectiveness

SkyWalker™ robot is currently the only Chinese-developed orthopedic surgical robot that features a self-developed mechanical arm, enabling it to assist in total knee arthroplasty (TKA) and total hip arthroplasty (THA). It is characterized by platformization, standardization, precision, and personalization.

Its planning system can establish a three-dimensional model of the knee and hip joints based on preoperative CT scan data. When facing patients with complex conditions, SkyWalker™ can generate personalized surgical plans based on the patients' physiological and anatomical characteristics, overcoming the traditional challenges of "limited visibility," "inaccurate bone-cutting," and "unsteady manipulation" during surgery. It achieves precise surgical guidance and keeps the surgical accuracy within the millimeter range.

During surgery, the independently developed high dexterity and lightweight mechanical arm is used to perform precise bone cutting and grinding at the "millimeter" level through human-robot collaboration. The postoperative correction of lower limb alignment is significantly better than traditional surgery, improving surgical precision and efficiency. The smaller incisions during surgery result in faster postoperative recovery for patients. Additionally, since the instruments used for hip joint resection, cup implantation, and knee joint bone cutting in SkyWalker™ are almost the same as those used in traditional surgeries, the learning curve for doctors is greatly shortened, facilitating rapid proficiency.

As of now, SkyWalker™ orthopedic robot has completed over 800 cases of robot-assisted clinical surgeries in the fields of orthopedics, joint surgery, and sports medicine across more than 40 hospitals in 16 provinces in China. These include numerous first-of-their-kind and challenging robot-assisted surgeries, such as the first domestic surgical robot 5G remote arthroplasty, intramedullary nail fixation for femoral shaft fractures, posterior joint replacement, and total joint replacement for severe rheumatoid arthritis. It has also assisted medical professionals in performing total knee arthroplasty surgeries in high-altitude and cold environments, demonstrating the robot's stable assistance and significant clinical value.

Mr. Liu Yu, Executive Vice President and Chief Commercial Officer of MicroPort^® MedBot^®, stated that the belief is to "Make surgery easier, safer and less invasive." not only within China but globally. Today, SkyWalker™, starting in China, has stepped onto the international stage, achieving multiple "firsts" and setting new clinical records overseas, earning high brand reputation for "Chinese-developed" high-end medical devices. This reflects the true portrayal of China's original high-end medical technology reshaping the global medical technology innovation landscape! As the shapers and leaders of the domestic surgical robot industry, MicroPort^® MedBot^® global strategy has been successfully implemented and expanded, bringing the concept of "making every surgery possible" to benefit the world.